These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12063401)

  • 1. Analysis of chromosomal aberrations involving chromosome 1q31-->q53 in a DMBA-induced rat fibrosarcoma cell line: amplification and overexpression of Jak2.
    Sjöling A; Lindholm H; Samuelson E; Yamasaki Y; Watanabe TK; Tanigami A; Levan G
    Cytogenet Cell Genet; 2001; 95(3-4):202-9. PubMed ID: 12063401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer.
    Zaharieva BM; Simon R; Diener PA; Ackermann D; Maurer R; Alund G; Knönagel H; Rist M; Wilber K; Hering F; Schönenberger A; Flury R; Jäger P; Fehr JL; Mihatsch MJ; Gasser T; Sauter G; Toncheva DI
    J Pathol; 2003 Dec; 201(4):603-8. PubMed ID: 14648664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification and overexpression of the hepatocyte growth factor receptor (HGFR/MET) in rat DMBA sarcomas.
    Helou K; Wallenius V; Qiu Y; Ohman F; Ståhl F; Klinga-Levan K; Kindblom LG; Mandahl N; Jansson JO; Levan G
    Oncogene; 1999 May; 18(21):3226-34. PubMed ID: 10359528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification.
    Bringuier PP; Tamimi Y; Schuuring E; Schalken J
    Oncogene; 1996 Apr; 12(8):1747-53. PubMed ID: 8622895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hgfr/Met oncogene acts as target for gene amplification in DMBA-induced rat sarcomas: free chromatin fluorescence in situ hybridization analysis of amplicon arrays in homogeneously staining regions.
    Helou K; Walentinsson A; Kost-Alimova M; Levan G
    Genes Chromosomes Cancer; 2001 Apr; 30(4):416-20. PubMed ID: 11241796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of candidate gene copy number alterations in the 11q13 region along with BRAF and NRAS mutations in human melanoma.
    Lázár V; Ecsedi S; Szöllosi AG; Tóth R; Vízkeleti L; Rákosy Z; Bégány A; Adány R; Balázs M
    Mod Pathol; 2009 Oct; 22(10):1367-78. PubMed ID: 19633643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification of Mycn, Ddx1, Rrm2, and Odc1 in rat uterine endometrial carcinomas.
    Karlsson A ; Helou K; Walentinsson A; Hedrich HJ; Szpirer C; Levan G
    Genes Chromosomes Cancer; 2001 Aug; 31(4):345-56. PubMed ID: 11433525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent allelic imbalance at the rat Pten locus in DMBA-induced fibrosarcomas.
    Sjöling A; Samuelson E; Adamovic T; Behboudi A; Röhme D; Levan G
    Genes Chromosomes Cancer; 2003 Jan; 36(1):70-9. PubMed ID: 12461751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification.
    Shuster MI; Han L; Le Beau MM; Davis E; Sawicki M; Lese CM; Park NH; Colicelli J; Gollin SM
    Genes Chromosomes Cancer; 2000 Jun; 28(2):153-63. PubMed ID: 10825000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGF4 and INT2 oncogenes are amplified and expressed in Kaposi's sarcoma.
    Kiuru-Kuhlefelt S; Sarlomo-Rikala M; Larramendy ML; Söderlund M; Hedman K; Miettinen M; Knuutila S
    Mod Pathol; 2000 Apr; 13(4):433-7. PubMed ID: 10786811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer.
    Hui R; Campbell DH; Lee CS; McCaul K; Horsfall DJ; Musgrove EA; Daly RJ; Seshadri R; Sutherland RL
    Oncogene; 1997 Sep; 15(13):1617-23. PubMed ID: 9380415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visualization of INT2 and HST1 amplification in oral squamous cell carcinomas.
    Lese CM; Rossie KM; Appel BN; Reddy JK; Johnson JT; Myers EN; Gollin SM
    Genes Chromosomes Cancer; 1995 Apr; 12(4):288-95. PubMed ID: 7539284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplification and overexpression of the EMS 1 oncogene, a possible prognostic marker, in human hepatocellular carcinoma.
    Yuan BZ; Zhou X; Zimonjic DB; Durkin ME; Popescu NC
    J Mol Diagn; 2003 Feb; 5(1):48-53. PubMed ID: 12552080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A region within murine chromosome 7F4, syntenic to the human 11q13 amplicon, is frequently amplified in 4NQO-induced oral cavity tumors.
    Yuan B; Oechsli MN; Hendler FJ
    Oncogene; 1997 Sep; 15(10):1161-70. PubMed ID: 9294609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2.
    Joos S; Granzow M; Holtgreve-Grez H; Siebert R; Harder L; Martín-Subero JI; Wolf J; Adamowicz M; Barth TF; Lichter P; Jauch A
    Int J Cancer; 2003 Feb; 103(4):489-95. PubMed ID: 12478664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MYEOV: a candidate gene for DNA amplification events occurring centromeric to CCND1 in breast cancer.
    Janssen JW; Cuny M; Orsetti B; Rodriguez C; Vallés H; Bartram CR; Schuuring E; Theillet C
    Int J Cancer; 2002 Dec; 102(6):608-14. PubMed ID: 12448002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCND1 and FGFR1 coamplification results in the colocalization of 11q13 and 8p12 sequences in breast tumor nuclei.
    Bautista S; Theillet C
    Genes Chromosomes Cancer; 1998 Aug; 22(4):268-77. PubMed ID: 9669664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detailed genomic mapping and expression analyses of 12p amplifications in pancreatic carcinomas reveal a 3.5-Mb target region for amplification.
    Heidenblad M; Jonson T; Mahlamäki EH; Gorunova L; Karhu R; Johansson B; Höglund M
    Genes Chromosomes Cancer; 2002 Jun; 34(2):211-23. PubMed ID: 11979555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancer.
    Lundgren K; Holm K; Nordenskjöld B; Borg A; Landberg G
    Breast Cancer Res; 2008; 10(5):R81. PubMed ID: 18823530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of CCND1 Locus Amplification by Fluorescence In Situ Hybridization.
    Balázs M; Koroknai V; Szász I; Ecsedi S
    Methods Mol Biol; 2018; 1726():85-100. PubMed ID: 29468546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.